Molecular inflammatory mediators in peripheral nerve degeneration and regeneration

NeuroImmunoModulation

Volumn 17, Issue 5, 2010, Pages 314-324

  Cámara Lemarroy, Carlos Rodrigo ^a   Guzmán De La Garza, Francisco Javier ^a   Fernández Garza, Nancy Esthela ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Cytokines; Immune system; Inflammation; Nerve injury; Regeneration; Wallerian degeneration

Indexed keywords

ARACHIDONIC ACID; GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOXYGENASE; MOLECULAR INFLAMMATORY MEDIATOR; PROSTAGLANDIN SYNTHASE; PROTEIN C JUN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

COMPLEMENT SYSTEM; DRUG MECHANISM; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; GENE TARGETING; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MOLECULAR BIOLOGY; NERVE DEGENERATION; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVE; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NERVE REGENERATION; PERIPHERAL NERVES; WALLERIAN DEGENERATION;

EID: 77950939844     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000292020     Document Type: Review

References (138)

1. Stoll G, Müller HW: Nerve injury, axonal degeneration and neural regeneration: basic insights. Brain Pathol 1999; 9: 313-325.
2. Koeppen AH: Wallerian degeneration: history and clinical significance. J Neurol Sci 2004; 220: 115-117.
3. Brück W: The role of macrophages in wallerian degeneration. Brain Pathol 1997; 7: 741-752.
4. Zochodne DW: The microenvironment of injured and regenerating peripheral nerves. Muscle Nerve Suppl 2000; 9: 33-38.
5. Hirschberg DL, Yoles E, Belkin M, Schwartz M: Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol 1994; 50: 9-16.
6. Karanth S, Yang G, Yeh J, Richardson PM: Nature of signals that initiate the immune response during Wallerian degeneration of peripheral nerves. Exp Neurol 2006; 202: 161-166.
7. Stoll G, Jander S, Myers RR: Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J Peripher Nerv Syst 2002; 7: 13-27.
8. Richardson PM, Lu X: Inflammation and axonal regeneration. J Neurol 1994; 242(1 suppl 1):57-60.
9. Nguyen MD, Julien JP, Rivest S: Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 2002; 3: 216-227.
10. Markiewski MM, Lambris JD: The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007; 171: 715-727.
11. Bonifati DM, Kishore U: Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 2007; 44: 999-1010.
12. Kulkarni AP, Kellaway LA, Lahiri DK, Kotwal GJ: Neuroprotection from complementmediated inflammatory damage. Ann NY Acad Sci 2004; 1035: 147-164.
13. de Jonge RR, van Schaik IN, Vreijling JP, Troost D, Baas F: Expression of complement components in the peripheral nervous system. Hum Mol Genet 2004; 13: 295-302.
14. Bonnard AS, Chan P, Fontaine M: Expression of clusterin and C4 mRNA during rat peripheral nerve regeneration. Immunopharmacology 1997; 38: 81-86.
15. Vedeler CA, Conti G, Bannerman P, Pleasure D: Expression of genes encoding receptors for IgG (FcRIII) and for C3b/C4b (Crry) in rat sciatic nerve during development and wallerian degeneration. J Neurosci Res 1992; 31: 654-661.
16. Brück W, Friede RL: The role of complement in myelin phagocytosis during PNS wallerian degeneration. J Neurol Sci 1991; 103: 182-187.
17. Hirata K, Mitoma H, Ueno N, He JW, Kawabuchi M: Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. J Neurocytol 1999; 28: 685-695.
18. Dailey AT, Avellino AM, Benthem L, Silver J, Kliot M: Complement depletion reduces macrophage infiltration and activation during wallerian degeneration and axonal regeneration. J Neurosci 1998; 18: 6713-6722.
19. Liu L, Lioudyno M, Tao R, Eriksson P, Svensson M, Aldskogius H: Hereditary absence of complement C5 in adult mice influences wallerian degeneration, but not retrograde responses, following injury to peripheral nerve. J Peripher Nerv Syst 1999; 4: 123-133.
20. Ramaglia V, Wolterman R, de Kok M, Vigar MA, Wagenaar-Bos I, King RH, Morgan BP, Baas F: Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury. Am J Pathol 2008; 172: 1043-1052.
21. Koski CL, Vanguri P, Shin ML: Activation of the alternative pathway of complement by human peripheral nerve myelin. J Immunol 1985; 134: 1810-1814. (Pubitemid 15130309)
22. Halstead SK, Humphreys PD, Goodfellow JA, Wagner ER, Smith RA, Willison HJ: Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome. Ann Neurol 2005; 58: 203-210.
23. Ramaglia V, King RH, Nourallah M, Wolterman R, de Jonge R, Ramkema M, Vigar MA, van der Wetering S, Morgan BP, Troost D, Baas F: The membrane attack complex of the complement system is essential for rapid Wallerian degeneration. J Neurosci 2007; 27: 7663-7672.
24. Stoll G, Schmidt B, Jander S, Toyka KV, Hartung HP: Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system. Ann Neurol 1991; 30: 147-155.
25. Dinarello CA: Proinflammatory cytokines. Chest 2000; 118: 503-508.
26. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP: Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 2005; 12: 255-269.
27. Opal SM, DePalo VA: Anti-inflammatory cytokines. Chest 2000; 117: 1162-1172.
28. Franzen R, Bouhy D, Schoenen J: Nervous system injury: focus on the inflammatory cytokine 'granulocyte-macrophage colony stimulating factor'. Neurosci Lett 2004; 361: 76-78.
29. Cacquevel M, Lebeurrier N, Chéenne S, Vivien D: Cytokines in neuroinflammation and Alzheimer's disease. Curr Drug Targets 2004; 5: 529-534.
30. Shamash S, Reichert F, Rotshenker S: The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin- 1alpha, and interleukin-1beta. J Neurosci 2002; 22: 3052-3060.
31. Hanada T, Yoshimura A: Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 2002; 13: 413-421.
32. Lindholm D, Heumann R, Meyer M, Thoenen H: Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987; 330: 658-659 (Pubitemid 18005581)
33. Rotshenker S, Aamar S, Barak V: Interleukin-1 activity in lesioned peripheral nerve. J Neuroimmunol 1992; 39: 75-80.
34. Temporin K, Tanaka H, Kuroda Y, Okada K, Yachi K, Moritomo H, Murase T, Yoshikawa H: IL-1beta promotes neurite outgrowth by deactivating RhoA via p38 MAPK pathway. Biochem Biophys Res Commun 2008; 365: 375-380.
35. Pineau I, Lacroix S: Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 2007; 500: 267-285.
36. George A, Buehl A, Sommer C: Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. Neurosci Lett 2004; 372: 215-219.
37. Créange A, Barlovatz-Meimon G, Gherardi RK: Cytokines and peripheral nerve disorders. Eur Cytokine Netw 1997; 8: 145-151.
38. Kobayashi S, Baba H, Uchida K, Shimada S, Negoro K, Takeno K, Yayama T, Yamada S, Yoshizawa H: Localization and changes of intraneural inflammatory cytokines and inducible- nitric oxide induced by mechanical compression. J Orthop Res 2005; 23: 771-778.
39. Korompilias AV, Chen LE, Seaber AV, Urbaniak JR: Interleukin-1 beta promotes functional recovery of crushed peripheral nerve. J Orthop Res 1999; 17: 714-719.
40. Stübgen JP: Tumor necrosis factor-alpha antagonists and neuropathy. Muscle Nerve 2008; 37: 281-292.
41. Siebert H, Brück W: The role of cytokines and adhesion molecules in axon degeneration after peripheral nerve axotomy: a study in different knockout mice. Brain Res 2003; 960: 152-156.
42. Leskovar A, Moriarty LJ, Turek JJ, Schoenlein IA, Borgens RB: The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J Exp Biol 2000; 203: 1783-1795.
43. Perrin FE, Lacroix S, Avilés-Trigueros M, David S: Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in wallerian degeneration. Brain 2005; 128: 854-866.
44. Liefner M, Maruschak B, Brück W: Concentration- dependent effects of pentoxifylline on migration and myelin phagocytosis by macrophages. J Neuroimmunol 1998; 89: 97-103.
45. Schäfers M, Schmidt C, Vogel C, Toyka KV, Sommer C: Tumor necrosis factor-alpha (TNF) regulates the expression of ICAM-1 predominantly through TNF receptor 1 after chronic constriction injury of mouse sciatic nerve. Acta Neuropathol 2002; 104: 197-205.
46. Liefner M, Siebert H, Sachse T, Michel U, Kollias G, Brück W: The role of TNF-alpha during Wallerian degeneration. J Neuroimmunol 2000; 108: 147-152.
47. Brück W, Brück Y, Friede RL: TNF-alpha suppresses CR3-mediated myelin removal by macrophages. J Neuroimmunol 1992; 38: 9-17.
48. Shubayev VI, Angert M, Dolkas J, Campana WM, Palenscar K, Myers RR: TNFalphainduced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci 2006; 31: 407-415.
49. Kamimura D, Ishihara K, Hirano T: IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003; 149: 1-38.
50. Lara-Ramírez R, Segura-Anaya E, Martínez- Gómez A, Dent MA: Expression of interleukin-6 receptor alpha in normal and injured rat sciatic nerve. Neuroscience 2008; 152: 601-608.
51. Cheepudomwit T, Güzelsu E, Zhou C, Griffin JW, Höke A: Comparison of cytokine expression profile during Wallerian degeneration of myelinated and unmyelinated peripheral axons. Neurosci Lett 2008; 430: 230-235.
52. Uçeyler N, Tscharke A, Sommer C: Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain. Brain Behav Immun 2007; 21: 553-560.
53. Rutkowski JL, Tuite GF, Lincoln PM, Boyer PJ, Tennekoon GI, Kunkel SL: Signals for proinflammatory cytokine secretion by human Schwann cells. J Neuroimmunol 1999; 101: 47-60.
54. Reichert F, Levitzky R, Rotshenker S: Interleukin 6 in intact and injured mouse peripheral nerves. Eur J Neurosci 1996; 8: 530-535.
55. Zhong J, Dietzel ID, Wahle P, Kopf M, Heumann R: Sensory impairments and delayed regeneration of sensory axons in interleukin- 6-deficient mice. J Neurosci 1999; 19: 4305-4313.
56. Hirota H, Kiyama H, Kishimoto T, Taga T: Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med 1996; 183: 2627-2634.
57. März P, Heese K, Dimitriades-Schmutz B, Rose-John S, Otten U: Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 1999; 26: 191-200.
58. Gölz G, Uhlmann L, Lüdecke D, Markgraf N, Nitsch R, Hendrix S: The cytokine/neurotrophin axis in peripheral axon outgrowth. Eur J Neurosci 2006; 24: 2721-2730.
59. Raivich G, Gehrmann J, Kreutzberg GW: Increase of macrophage colony-stimulating factor and granulocyte-macrophage colonystimulating factor receptors in the regenerating rat facial nucleus. J Neurosci Res 1991; 30: 682-686.
60. Mirski R, Reichert F, Klar A, Rotshenker S: Granulocyte macrophage colony stimulating factor (GM-CSF) activity is regulated by a GM-CSF binding molecule in wallerian degeneration following injury to peripheral nerve axons. J Neuroimmunol 2003; 140: 88-96.
61. Saada A, Reichert F, Rotshenker S: Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol 1996; 133: 159-167.
62. Be'eri H, Reichert F, Saada A, Rotshenker S: The cytokine network of wallerian degeneration: IL-10 and GM-CSF. Eur J Neurosci 1998; 10: 2707-2713.
63. Taskinen HS, Olsson T, Bucht A, Khademi M, Svelander L, Röyttä M: Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA. J Neuroimmunol 2000; 102: 17-25.
64. Jander S, Pohl J, Gillen C, Stoll G: Differential expression of interleukin-10 mRNA in wallerian degeneration and immune-mediated inflammation of the rat peripheral nervous system. J Neurosci Res 1996; 43: 254-259.
65. Gillen C, Jander S, Stoll G: Sequential expression of mRNA for proinflammatory cytokines and interleukin-10 in the rat peripheral nervous system: comparison between immune-mediated demyelination and wallerian degeneration. J Neurosci Res 1998; 51: 489-496.
66. George A, Kleinschnitz C, Zelenka M, Brinkhoff J, Stoll G, Sommer C: Wallerian degeneration after crush or chronic constriction injury of rodent sciatic nerve is associated with a depletion of endoneurial interleukin-10 protein. Exp Neurol 2004; 188: 187-191.
67. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Bührer C, Stahel PF: IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci 2005; 28: 487-493.
68. Menge T, Jander S, Stoll G: Induction of the proinflammatory cytokine interleukin-18 by axonal injury. Neurosci Res 2001; 65: 332-339.
69. Huang Z, Ha GK, Petitto JM: IL-15 and IL- 15R alpha gene deletion: effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy. Neurosci Lett 2007; 417: 160-164.
70. Dass CR, Choong PF: C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies. Pharmazie 2008; 63: 411-414.
71. Mattson MP, Meffert MK: Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ 2006; 13: 852-860.
72. Lee SJ, Lee S: Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy 2002; 1: 181-191.
73. Grilli M, Memo M: Nuclear factor-kappaB/ Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol 1999; 57: 1-7.
74. Pollock G, Pennypacker KR, Mémet S, Israël A, Saporta S: Activation of NF-kappaB in the mouse spinal cord following sciatic nerve transection. Exp Brain Res 2005; 165: 470-477.
75. Isenmann S, Bähr M: Expression of c-Jun protein in degenerating retinal ganglion cells after optic nerve lesion in the rat. Exp Neurol 1997; 147: 28-36.
76. Yang L, Tao LY, Chen XP: Roles of NF-kappaB in central nervous system damage and repair. Neurosci Bull 2007; 23: 307-313.
77. Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, Quan N: Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine- mediated pain facilitation. Eur J Neurosci 2005; 22: 1977-1986.
78. Sun T, Song WG, Fu ZJ, Liu ZH, Liu YM, Yao SL: Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. Br J Anaesth 2006; 97: 553-558.
79. Coutaux A, Adam F, Willer JC, Le Bars D: Hyperalgesia and allodynia: peripheral mechanisms. Joint Bone Spine 2005; 72: 359-371. (Pubitemid 41415822)
80. Niederberger E, Geisslinger G: The IKK-NFkappaB pathway: a source for novel molecular drug targets in pain therapy? FASEB J 2008; 22: 3432-3442.
81. Sakaue G, Shimaoka M, Fukuoka T, Hiroi T, Inoue T, Hashimoto N, Sakaguchi T, Sawa Y, Morishita R, Kiyono H, Noguchi K, Mashimo T: NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 2001; 12: 2079-2084.
82. Andorfer B, Kieseier BC, Mathey E, Armati P, Pollard J, Oka N, Hartung HP: Expression and distribution of transcription factor NFkappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol 2001; 116: 226-232.
83. Laurà M, Mazzeo A, Aguennouz M, Santoro M, Catania MA, Migliorato A, Calapai G, Vita G: Immunolocalization and activation of nuclear factor-kappaB in the sciatic nerves of rats with experimental autoimmune neuritis. J Neuroimmunol 2006; 174: 32-38.
84. Ma W, Bisby MA: Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res 1998; 797: 243-254.
85. Wu LC, Goettl VM, Madiai F, Hackshaw KV, Hussain SR: Reciprocal regulation of nuclear factor kappa B and its inhibitor ZAS3 after peripheral nerve injury. BMC Neurosci 2006; 7: 4.
86. Wang Y, Kawamura N, Schmelzer JD, Schmeichel AM, Low PA: Decreased peripheral nerve damage after ischemia-reperfusion injury in mice lacking TNF-alpha. J Neurol Sci 2008; 267: 107-111.
87. Fernyhough P, Smith DR, Schapansky J, Van Der Ploeg R, Gardiner NJ, Tweed CW, Kontos A, Freeman L, Purves-Tyson TD, Glazner GW: Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons. J Neurosci 2005; 25: 1682-1690.
88. Hirata H, Hibasami H, Yoshida T, Ogawa M, Matsumoto M, Morita A, Uchida A: Nerve growth factor signaling of p75 induces differentiation and ceramide-mediated apoptosis in Schwann cells cultured from degenerating nerves. Glia 2001; 36: 245-258.
89. Maggirwar SB, Sarmiere PD, Dewhurst S, Freeman RS: Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J Neurosci 1998; 18: 10356-10365.
90. Nickols JC, Valentine W, Kanwal S, Carter BD: Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 2003; 6: 161-167.
91. Stewart HJ: Expression of c-Jun, Jun B, Jun D and cAMP response element binding protein by Schwann cells and their precursors in vivo and in vitro. Eur J Neurosci 1995; 7: 1366-1375.
92. Hunt D, Hossain-Ibrahim K, Mason MR, Coffin RS, Lieberman AR, Winterbottom J, Anderson PN: ATF3 upregulation in glia during Wallerian degeneration: differential expression in peripheral nerves and CNS white matter. BMC Neurosci 2004; 5: 9.
93. Bisby MA, Tetzlaff W, Brown MC: Cell body response to injury in motoneurons and primary sensory neurons of a mutant mouse, Ola (Wld), in which wallerian degeneration is delayed. J Comp Neurol 1995; 359: 653-662.
94. Gold BG, Austin DR, Storm-Dickerson T: Multiple signals underlie the axotomy-induced up-regulation of c-JUN in adult sensory neurons. Neurosci Lett 1994; 176: 123-127.
95. Gold BG, Storm-Dickerson T, Austin DR: Regulation of the transcription factor c-JUN by nerve growth factor in adult sensory neurons. Neurosci Lett 1993; 154: 129-133.
96. Jessen KR, Mirsky R: Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 2008; 56: 1552-1565.
97. Zhang P, Miller BS, Rosenzweig SA, Bhat NR: Activation of C-jun N-terminal kinase/ stress-activated protein kinase in primary glial cultures. J Neurosci Res 1996; 46: 114-121.
98. Arancibia SA, Beltrán CJ, Aguirre IM, Silva P, Peralta AL, Malinarich F, Hermoso MA: Toll-like receptors are key participants in innate immune responses. Biol Res 2007; 40: 97-112.
99. Sandor F, Buc M: Toll-like receptors. I. Structure, function and their ligands. Folia Biol (Praha) 2005; 51: 148-157.
100. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T: Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 2003; 100: 8514-8519.
101. Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, Choi SY, Park K, Kim JS, Akira S, Na HS, Oh SB, Lee SJ: A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 2007; 282: 14975-14983.
102. Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, Dai Y, Fukuoka T, Akira S, Noguchi K: Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J Neurochem 2008; 105: 2249-2259.
103. Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG: Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 2007; 102: 37-50.
104. Lee H, Jo EK, Choi SY, Oh SB, Park K, Kim JS, Lee SJ: Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem Biophys Res Commun 2006; 350: 742-747.
105. Boivin A, Pineau I, Barrette B, Filali M, Vallières N, Rivest S, Lacroix S: Toll-like receptor signaling is critical for wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci 2007; 27: 12565-12576.
106. Homaidan FR, Chakroun I, Haidar HA, El- Sabban ME: Protein regulators of eicosanoid synthesis: role in inflammation. Curr Protein Pept Sci 2002; 3: 467-484.
107. Parente L, Perretti M: Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol 2003; 65: 153-159.
108. Crofford LJ: COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol Suppl 1997; 49: 15-19.
109. Tzeng SF, Hsiao HY, Mak OT: Prostaglandins and cyclooxygenases in glial cells during brain inflammation. Curr Drug Targets Inflamm Allergy 2005; 4: 335-340.
110. Phillis JW, Horrocks LA, Farooqui AA: Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. Brain Res Rev 2006; 52: 201-243.
111. Ma W, Quirion R: Does COX2-dependent PGE2 play a role in neuropathic pain? Neurosci Lett 2008; 437: 165-169.
112. Ma W, Eisenach JC: Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci 2002; 15: 1037-1047.
113. Takahashi M, Kawaguchi M, Shimada K, Konishi N, Furuya H, Nakashima T: Cyclooxygenase-2 expression in Schwann cells and macrophages in the sciatic nerve after single spinal nerve injury in rats. Neurosci Lett 2004; 363: 203-206.
114. Syriatowicz JP, Hu D, Walker JS, Tracey DJ: Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience 1999; 94: 587-594. (Pubitemid 29436084)
115. Durrenberger PF, Facer P, Casula MA, Yiangou Y, Gray RA, Chessell IP, Day NC, Collins SD, Bingham S, Wilson AW, Elliot D, Birch R, Anand P: Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a timecourse study. BMC Neurol 2006; 6: 1.
116. Ma W, Eisenach JC: Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury. Neuroscience 2003; 121: 691-704.
117. Shin T, Lee Y, Sim KB: Involvement of cyclooxygenase-1 and -2 in the sciatic nerve of rats with experimental autoimmune neuritis. Immunol Invest 2003; 32: 123-130.
118. Schwab JM, Brechtel K, Nguyen TD, Schluesener HJ: Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/ macrophages and upregulation by endothelium following spinal cord injury. J Neuroimmunol 2000; 111: 122-130.
119. Muja N, DeVries GH: Prostaglandin E(2) and 6-keto-prostaglandin F(1alpha) production is elevated following traumatic injury to sciatic nerve. Glia 2004; 46: 116-129.
120. Marshall JS, Gomi K, Blennerhassett MG, Bienenstock J: Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol 1999; 162: 4271-4276.
121. Fu Q, Hue J, Li S: Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition. J Neurosci 2007; 27: 4154-4164.
122. Klegeris A, McGeer PL: Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging 2002; 23: 787-794.
123. Camara-Lemarroy CR, Guzman-de la Garza FJ, Barrera-Oranday EA, Cabello-Garcia AJ, Garcia-Tamez A, Fernandez-Garza NE: Celecoxib accelerates functional recovery after sciatic nerve crush in the rat. J Brachial Plex Peripher Nerve Inj 2008; 3: 25.
124. Amer RK, Pace-Asciak CR, Mills LR: A lipoxygenase product, hepoxilin A(3), enhances nerve growth factor-dependent neurite regeneration post-axotomy in rat superior cervical ganglion neurons in vitro. Neuroscience 2003; 116: 935-946.
125. Shin T, Min DS, Ahn M, Son W, Matsumoto Y: Increased expression of phospholipase D1 in the sciatic nerve of rats with experimental autoimmune neuritis. Immunol Invest 2002; 31: 169-176.
126. De S, Trigueros MA, Kalyvas A, David S: Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during wallerian degeneration. Mol Cell Neurosci 2003; 24: 753-765.
127. López-Vales R, Navarro X, Shimizu T, Baskakis C, Kokotos G, Constantinou-Kokotou V, Stephens D, Dennis EA, David S: Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain 2008; 131: 2620-2631.
128. Martini R, Fischer S, López-Vales R, David S: Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 2008; 56: 1566-1577.
129. Sosa I, Reyes O, Kuffler DP: Immunosuppressants: neuroprotection and promoting neurological recovery following peripheral nerve and spinal cord lesions. Exp Neurol 2005; 195: 7-15.
130. Weber RV, Mackinnon SE: Bridging the neural gap. Clin Plast Surg 2005; 32: 605-616.
131. Mika J: Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Pharmacol Rep 2008; 60: 297-307.
132. Zochodne DW, Levy D: Nitric oxide in damage, disease and repair of the peripheral nervous system. Cell Mol Biol (Noisyle- grand) 2005; 51: 255-267.
133. Ha GK, Parikh S, Huang Z, Petitto JM: Influence of injury severity on the rate and magnitude of the T lymphocyte and neuronal response to facial nerve axotomy. J Neuroimmunol 2008; 199: 18-23.
134. Temporin K, Tanaka H, Kuroda Y, Okada K, Yachi K, Moritomo H, Murase T, Yoshikawa H: Interleukin-1 beta promotes sensory nerve regeneration after sciatic nerve injury. Neurosci Lett 2008; 440: 130-133.
135. Chen LE, Seaber AV, Wong GH, Urbaniak JR: Tumor necrosis factor promotes motor functional recovery in crushed peripheral nerve. Neurochem Int 1996; 29: 197-203.
136. Lindenlaub T, Teuteberg P, Hartung T, Sommer C: Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res 2000; 866: 15-22.
137. Atkins S, Loescher AR, Boissonade FM, Smith KG, Occleston N, O'Kane S, Ferguson MW, Robinson PP: Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repair. J Peripher Nerv Syst 2007; 12: 269-276.
138. Shuto T, Horie H, Hikawa N, Sango K, Tokashiki A, Murata H, Yamamoto I, Ishikawa Y: IL-6 up-regulates CNTF mRNA expression and enhances neurite regeneration. Neuroreport 2001; 12: 1081-1085.